Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Precision Biologics proves efficacy against various human cancer types
Date 10 November 2025

Precision Biologics proves efficacy against various human cancer types

Announcement Precision Biologics, Inc. declared in vivo and in vitro efficacy of its novel tumor-specific ADC (PB-vcMMAE-5) in competition against human carcinomas reacting with truncated core 2 O-g...

OrsoBio's new data to highlight in ObesityWeek® 2025
Date 07 November 2025

OrsoBio's new data to highlight in ObesityWeek® 2025

Announcement OrsoBio, a leading clinical-level biopharmaceutical company working towards the development of related metabolic disorders and obesity treatments, have showcased the presentation of new ...

United Therapeutics' transplantation success in its extensive trial
Date 06 November 2025

United Therapeutics' transplantation success in its extensive trial

Announcement The leading United Therapeutics Corporation has completed its first clinical xenotransplantation in its EXPAND study, using UKidney™ in patients with end-stage renal disease (ESRD)...

Estrella's unmodified second dose cohort of its ongoing trial to cure the Advanced B-Cell NHL condition
Date 06 November 2025

Estrella's unmodified second dose cohort of its ongoing trial to cure the Advanced B-Cell NHL condition

Announcement Estrella Immunopharma, Inc., a leading clinical-level biopharmaceutical company establishing CD19 and CD22-focused ARTEMIS® T-cell therapies to provide treatment to autoimmune and c...

Immunis research showed multifaceted benefits in aged models
Date 05 November 2025

Immunis research showed multifaceted benefits in aged models

Announcement Immunis, Inc., a clinical-level biotech establishing creative stem cell empowered biologics for disease and age-based immune dysregulation, has officially published peer-reviewed resear...

Forlong's first patients' dosage completion under a clinical trial for NMIBC
Date 04 November 2025

Forlong's first patients' dosage completion under a clinical trial for NMIBC

Announcement Forlong Biotechnology, a leading clinical-level biotech company, aims to establish a transitional change in cytokine therapies for extreme unmet needs for a certain patient group proudly...

Tectonic positive data to relieve group 2 pulmonary hypertension in HFrEF
Date 03 November 2025

Tectonic positive data to relieve group 2 pulmonary hypertension in HFrEF

Image Credit: Tectonic Therapeutic Announcement  The Tectonic Therapeutic Inc. has showcased its successful positive topline results from the phase 1b part B acute hemodynamic clinical trial ...

Ferring's new research with ADSTILADRIN® adds a new feather to clinical practice
Date 31 October 2025

Ferring's new research with ADSTILADRIN® adds a new feather to clinical practice

Image Credit: Ferring Pharmaceuticals Announcement  Ferring Pharmaceuticals confirmed that three abstracts focusing on ADSTILADRIN will be showcased at the 101st Annual Meeting of the Western...

BridgeBio's lands on late-stage limb-girdle muscular dystrophy data
Date 30 October 2025

BridgeBio's lands on late-stage limb-girdle muscular dystrophy data

Announcement The bridgeBio Pharma’s in-progress investigational oral small molecule BBP-418, an under-development study to cure a particular form of limb-girdle muscular dystrophy, has entered ...

Uniqure's gene therapy, a new ray of hope for patients
Date 29 October 2025

Uniqure's gene therapy, a new ray of hope for patients

Announcement The uniqueness of gene therapy for Huntington’s disease’s pivotal results is a new ray of hope for patients disappointed in the past few years. Though one expert is concerne...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.